Roche's IMpower133 offers a glimpse at rare progress in fight against small cell lung cancer
Last summer Roche’s big R&D group at Genentech heralded a breakthrough with positive survival and disease progression data for its frontline study of its checkpoint …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
